This brand name is authorized in Japan
The drug NAPAGELN contains one active pharmaceutical ingredient (API):
|
1
Felbinac
UNII 94WNJ5U8L7 - FELBINAC
|
|
Felbinac is an active metabolite of fenbufen, belonging to the family of medicines known as nonsteroidal anti-inflammatory drugs (NSAIDs). It is used as a gel for local treatment of pain and inflammation associated with conditions of the musculo-skeletal system. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| M02AA08 | Felbinac | M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain → M02AA Antiinflammatory preparations, non-steroids for topical use |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 2649731M1071, 2649731N1034, 2649731Q1065 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
